A team of researchers at VCU Massey Comprehensive Cancer Center discovered an innovative way to use a drug already approved ...

Researchers have identified beta (β) catenin degradation as a critical and previously unrecognised vulnerability in B cell ...

Researchers identify beta catenin protein degradation as a therapeutic vulnerability in B cell acute lymphoblastic leukaemia, supporting the repurposing of glycogen synthase kinase 3 beta inhibitors.

DelveInsight's DUB Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

Pancreatic cancer may evade the immune system not by accident but by actively switching off internal danger signals through ...

The cancer gene MYC camouflages tumors by suppressing alarm signals that normally activate the immune system.

MYC targeted therapies offer significant market opportunities, driven by their potential as oncogenic drivers in diverse tumors. The field sees growing R&D on innovative platforms, early-stage ...

The cancer gene MYC camouflages tumors by suppressing alarm signals that normally activate the immune system. This finding from a new study offers a promising way to improve existing cancer therapies ...

The cancer gene MYC camouflages tumours by suppressing alarm signals that normally activate the immune system. This finding from a new study offers a promising way to improve existing cancer therapies ...

The study examines how pyruvate, a key product of glycolysis that influences TCA metabolism and gluconeogenesis, impacts cellular metabolism and cell size. It primarily utilizes the Drosophila ...